Ultragenyx Pharmaceutical (RARE) Work In Process (2017 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Work In Process of $32 million for Q2 2026, up 62.0% from $19.76 million a year earlier but down 3.0% from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Work In Process (2017 - 2026) Analysis & Trends
At the end of FY2025, Ultragenyx Pharmaceutical posted Work In Process of $27 million, up 22.7% from FY2024.
- Work In Process has increased for five consecutive years, with a five-year compound annual growth rate of 30.3% (FY2020 to FY2025).
- By year, Work In Process came in at $22 million in FY2024 (+16.7%), $18.86 million in FY2023 (+7.9%), $17.49 million in FY2022 (+66.5%) and $10.5 million in FY2021 (+46.2%).
- Five-year quarterly Work In Process spans a low of $9.55 million in Q3 2021 and a high of $33 million in Q1 2026.
- Year over year, Work In Process has now increased in each of the last four quarters, with growth averaging 21.7% over the last eight quarters.
- The high point for year-over-year Work In Process in five years was Q1 2022 (growth of 76.8%); the low point was Q2 2025 (a decline of 21.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $33 million (Q1 2026), $27 million (Q4 2025) and $29.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.51 Bn | -292.70 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.00 Mn |
| Mar 31, 2026 | 33.00 Mn |
| Dec 31, 2025 | 27.00 Mn |
| Sep 30, 2025 | 29.19 Mn |
| Jun 30, 2025 | 19.76 Mn |
| Mar 31, 2025 | 22.91 Mn |
| Dec 31, 2024 | 22.00 Mn |
| Sep 30, 2024 | 20.28 Mn |
| Jun 30, 2024 | 25.25 Mn |
| Mar 31, 2024 | 22.82 Mn |
| Dec 31, 2023 | 18.86 Mn |
| Sep 30, 2023 | 19.17 Mn |
| Jun 30, 2023 | 18.54 Mn |
| Mar 31, 2023 | 15.09 Mn |
| Dec 31, 2022 | 17.49 Mn |
| Sep 30, 2022 | 15.78 Mn |
| Jun 30, 2022 | 16.19 Mn |
| Mar 31, 2022 | 11.99 Mn |
| Dec 31, 2021 | 10.50 Mn |
| Sep 30, 2021 | 9.55 Mn |
API Access
Ultragenyx Pharmaceutical Work In Process API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=work-in-process&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "work-in-process", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=work-in-process&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();